Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Reveal Pharmaceuticals Inc.
Virginia Commonwealth University
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Radiation Therapy Oncology Group
Assistance Publique Hopitaux De Marseille
University of Iowa
Wake Forest University Health Sciences
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
UNICANCER
Northwestern University
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
NYU Langone Health
National Cancer Institute (NCI)
University of Utah
SWOG Cancer Research Network
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Centre Hospitalier Universitaire Vaudois
Barbara Ann Karmanos Cancer Institute
Duke University